Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Shenzhen YHLO Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Cash & Equivalents	496.17	464.97	490.59	1,251	478.85	232.36
Short-Term Investments	119.05	182.36	143.6	68.57	-	-
Trading Asset Securities	18.41	69.59	76.66	114.16	16.15	-
Cash & Short-Term Investments	633.63	716.93	710.85	1,433	495	232.36
Cash Growth	9.55%	0.85%	-50.40%	189.56%	113.03%	54.21%
Accounts Receivable	558.1	523.85	414.19	346.38	254.43	213.6
Other Receivables	27.49	54.23	48.11	66.2	21.48	9.43
Receivables	585.59	578.08	462.3	412.58	275.91	223.03
Inventory	623.24	670.77	634.5	569.54	363.81	298.16
Other Current Assets	101.26	45.98	43.08	79.72	43.34	40.32
Total Current Assets	1,944	2,012	1,851	2,495	1,178	793.88
Property, Plant & Equipment	1,766	1,735	1,371	1,044	672.07	425.35
Long-Term Investments	239.39	358.17	260.91	302.82	75.42	-
Goodwill	5.29	5.29	5.29	5.29	-	-
Other Intangible Assets	165.06	182.88	188.98	210.07	103.78	35.75
Long-Term Accounts Receivable	-	-	-	-	3.76	3.99
Long-Term Deferred Tax Assets	40.42	44.01	47.68	50.57	16.81	13.53
Long-Term Deferred Charges	29.21	26.97	43.12	36.15	22.87	25.05
Other Long-Term Assets	48.73	51	37.89	69.9	65.05	26.09
Total Assets	4,238	4,415	3,806	4,214	2,138	1,324
Accounts Payable	186.72	213.13	203.81	307.76	137.6	73.74
Accrued Expenses	57.06	164.42	145.99	211.11	54.88	37.06
Short-Term Debt	358.6	292.32	171.07	279.36	150.82	302
Current Portion of Long-Term Debt	37.15	23.8	-	-	-	-
Current Portion of Leases	-	1.84	1.07	5.05	4.73	4.81
Current Income Taxes Payable	19.12	4.59	13.27	75.73	12.27	15.16
Current Unearned Revenue	172.77	184.5	183.51	528.61	111.09	58.94
Other Current Liabilities	109.3	173.11	122.56	126.24	40.79	28.94
Total Current Liabilities	940.73	1,058	841.28	1,534	512.17	520.65
Long-Term Debt	586.24	585.44	381.89	183.9	73.26	-
Long-Term Leases	1.9	2.39	3.57	5.24	4.89	8.22
Long-Term Unearned Revenue	62.78	62.52	36.7	29.75	33.25	30.8
Long-Term Deferred Tax Liabilities	1.84	4.54	9.06	15.88	0.02	-
Other Long-Term Liabilities	2.1	0.74	-	-	-	-
Total Liabilities	1,596	1,713	1,273	1,769	623.59	559.67
Common Stock	570.43	570.27	568.13	567	405	364
Additional Paid-In Capital	486.52	480.36	432.24	389.51	525.03	13.24
Retained Earnings	1,633	1,692	1,546	1,447	595.8	391.05
Comprehensive Income & Other	13.21	14.38	13.53	13.84	-0.12	-0.5
Total Common Equity	2,703	2,757	2,560	2,417	1,526	767.79
Minority Interest	-60.62	-55.32	-26.27	28.1	-11.49	-3.81
Shareholders' Equity	2,642	2,702	2,534	2,445	1,514	763.98
Total Liabilities & Equity	4,238	4,415	3,806	4,214	2,138	1,324
Total Debt	983.89	905.79	557.6	473.55	233.69	315.03
Net Cash (Debt)	-350.27	-188.86	153.25	959.74	261.31	-82.67
Net Cash Growth	-	-	-84.03%	267.28%	-	-
Net Cash Per Share	-0.64	-0.33	0.27	1.69	0.48	-0.16
Filing Date Shares Outstanding	570.43	570.27	568.13	567	567	509.6
Total Common Shares Outstanding	570.43	570.27	568.13	567	567	509.6
Working Capital	1,003	954.06	1,009	961.27	665.88	273.23
Book Value Per Share	4.74	4.83	4.51	4.26	2.69	1.51
Tangible Book Value	2,532	2,569	2,366	2,202	1,422	732.04
Tangible Book Value Per Share	4.44	4.50	4.16	3.88	2.51	1.44
Buildings	-	891.92	342.69	322.37	222.47	163.14
Machinery	-	1,370	1,069	817.66	582.7	384.94
Construction In Progress	-	168.82	460.54	256.9	96.49	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.